Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Urenco ChemPlants Read moreSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report10 November 2016
On 19 October, Urenco and its project partners achieved 2million safe working hours on the construction of its Tails Management Facility (TMF) at Urenco Capenhurst.
To mark this safe working milestone, Urenco and its project partners - Jacobs, Balfour Beatty, Kier, Laker Vent Engineering, Rainham Industrial Services and M&W Hargreaves - are donating £15,000 to three local charities.
The chosen charities are Claire House Children’s Hospice, Zoe’s Place and Medcare.
Commenting on the donation, Pleun E. Schuddebeurs, Managing Director, Urenco ChemPlants said:
“Safety is always Urenco's core priority and we are proud to have achieved this significant milestone of two million safe working hours on our Tails Management Facility project. To recognise this achievement, our employees have chosen to donate to three charities, who continue to make a difference in our local community.”
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries